Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof
申请人:Ishikawa, Masayuki
公开号:EP0040793A1
公开(公告)日:1981-12-02
A 5,6,7-substituted-2,4 (1H,3H)-quinazolinedione compound of the formula (I),
wherein R1, R2, R3, A and B as defined in claim 1 and its acid addition salt; and a vasodilating and hypotensive composition containing the aforesaid compound.
一种式(I)的 5,6,7-取代的-2,4(1H,3H)-喹唑啉二酮化合物、
其中 R1、R2、R3、A 和 B 如权利要求 1 所定义及其酸加成盐;以及含有上述化合物的血管扩张和降血压组合物。
Substituted 6-(thien-2-yl)-3(2H)-pyridazinones and processes for their preparation
申请人:A. Nattermann & Cie. GmbH
公开号:EP0128502A1
公开(公告)日:1984-12-19
The invention refers to substituted 6-(thien-2-yl)-3(2H)-pyridazinones of formula I
and processes for their preparation.
本发明涉及式 I 的取代 6-(噻吩-2-基)-3(2H)-哒嗪酮及其制备方法。
及其制备工艺。
Compositions providing improved functionalization of terminal anions and processes for improved functionalization of terminal anions
申请人:——
公开号:US20020010082A1
公开(公告)日:2002-01-24
Compositions including one or more anionic polymerization initiators and one or more additives for improving functionalizing efficiency of living polymer anions are disclosed. The present invention also provides compositions including one or more electrophiles and one or more additives for improving functionalizing efficiency of living polymer anions. Novel electrophiles and processes for improving polymer anion functionalization efficiencies are also disclosed.